ArticleFrontiers in pharmacology2018

Epigenome-Wide Association Study of Soluble Tumor Necrosis Factor Receptor 2 Levels in the Framingham Heart Study.

Michael M Mendelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.